InvestorsHub Logo
Followers 28
Posts 398
Boards Moderated 0
Alias Born 12/10/2015

Re: None

Monday, 01/28/2019 3:27:05 PM

Monday, January 28, 2019 3:27:05 PM

Post# of 462570
Patent news? Unsure if this was posted here before, but this patent has a 1/24/19 publication date. Thoughts?

https://patentscope.wipo.int/search/en/detail.jsf?docId=US236451262&tab=NATIONALBIBLIO&office=&prevFilter=%26fq%3DICF_M%3A%22A61K%22&sortOption=Pub+Date+Desc&queryString=&recNum=213&maxRec=2035248

This invention addresses tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73, AV2-73, or A2-73) in a method of treatment for neurodevelopmental disorders. Particular reference is made to the treatment of autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, and Smith-Magenis syndrome. Additional reference is made to multiple sclerosis.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News